UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 230

Sortiert nach

Aerobic vs. resistance exercise in non-alcoholic fatty liver disease: A systematic review

Journal of hepatology, 2017-01, Vol.66 (1), p.142-152

2017

Link zum Volltext

Verfügbarkeit prüfen

Characteristics of non-obese non-alcoholic fatty liver disease: Effect of genetic and environmental factors

Hepatology research, 2016-09, Vol.46 (10), p.1011-1018

2016

Link zum Volltext

Verfügbarkeit prüfen

Wheat-bran autolytic peptides containing a branched-chain amino acid attenuate non-alcoholic steatohepatitis via the suppression of oxidative stress and the upregulation of AMPK/ACC in high-fat diet-fed mice

International journal of molecular medicine, 2017-02, Vol.39 (2), p.407-414

2017

Link zum Volltext

Verfügbarkeit prüfen

Association of polymorphisms in GCKR and TRIB1 with nonalcoholic fatty liver disease and metabolic syndrome traits

Endocrine Journal, 2014, Vol.61(7), pp.683-689

2014

Link zum Volltext

Verfügbarkeit prüfen

Hepatitis C Virus Down-Regulates Insulin Receptor Substrates 1 and 2 through Up-Regulation of Suppressor of Cytokine Signaling 3

The American journal of pathology, 2004-11, Vol.165 (5), p.1499-1508

2004

Link zum Volltext

Verfügbarkeit prüfen

Luteolin promotes degradation in signal transducer and activator of transcription 3 in human hepatoma cells : An implication for the antitumor potential of flavonoids

Cancer research (Chicago, Ill.), 2006-05, Vol.66 (9), p.4826-4834

2006

Link zum Volltext

Verfügbarkeit prüfen

Association of the rs738409 polymorphism in PNPLA3 with liver damage and the development of nonalcoholic fatty liver disease

BMC medical genetics, 2010-12, Vol.11 (1), p.172-172, Article 172

2010

Link zum Volltext

Verfügbarkeit prüfen

Significance and Therapeutic Potential of Endothelial Progenitor Cell Transplantation in a Cirrhotic Liver Rat Model

Gastroenterology (New York, N.Y. 1943), 2007-07, Vol.133 (1), p.91-107.e1

2007

Link zum Volltext

Verfügbarkeit prüfen

Survival Benefit of Hepatic Arterial Infusion Chemotherapy over Sorafenib in the Treatment of Locally Progressed Hepatocellular Carcinoma

Cancers, 2021-02, Vol.13 (4), p.646

2021

Link zum Volltext

Verfügbarkeit prüfen

Antiangiogenic and Antitumor Activities of Aflibercept, a Soluble VEGF Receptor-1 and -2, in a Mouse Model of Hepatocellular Carcinoma

Neoplasia (New York, N.Y.), 2016-07, Vol.18 (7), p.413-424

2016

Link zum Volltext

Verfügbarkeit prüfen

Branched-Chain Amino Acid–Rich Supplements Containing Microelements Have Antioxidant Effects on Nonalcoholic Steatohepatitis in Mice

JPEN. Journal of parenteral and enteral nutrition, 2016-05, Vol.40 (4), p.519-528

2016

Link zum Volltext

Verfügbarkeit prüfen

Vandetanib, an Inhibitor of VEGF Receptor-2 and EGF Receptor, Suppresses Tumor Development and Improves Prognosis of Liver Cancer in Mice

Clinical cancer research, 2012-07, Vol.18 (14), p.3924-3933

2012

Link zum Volltext

Verfügbarkeit prüfen

Pigment epithelium-derived factor (PEDF) inhibits survival and proliferation of VEGF-exposed multiple myeloma cells through its anti-oxidative properties

Biochemical and biophysical research communications, 2013-02, Vol.431 (4), p.693-697

2013

Link zum Volltext

Verfügbarkeit prüfen

Targeted next-generation sequencing and fine linkage disequilibrium mapping reveals association of PNPLA3 and PARVB with the severity of nonalcoholic fatty liver disease

Journal of human genetics, 2014-05, Vol.59 (5), p.241-246

2014

Link zum Volltext

Verfügbarkeit prüfen

Transplantation of endothelial progenitor cells ameliorates vascular dysfunction and portal hypertension in carbon tetrachloride-induced rat liver cirrhotic model

Journal of gastroenterology and hepatology, 2013-01, Vol.28 (1), p.168-178

2013

Link zum Volltext

Verfügbarkeit prüfen

Angiogenic cell therapy for hepatic fibrosis

Medical molecular morphology, 2006-03, Vol.39 (1), p.16-21

2006

Link zum Volltext

Verfügbarkeit prüfen

Metronomic Chemotherapy: Possible Clinical Application in Advanced Hepatocellular Carcinoma

Translational oncology, 2013-10, Vol.6 (5), p.511-519

2013

Link zum Volltext

Verfügbarkeit prüfen

Hepatitis C virus core protein upregulates the expression of vascular endothelial growth factor via the nuclear factor-κB/hypoxia-inducible factor-1α axis under hypoxic conditions

Hepatology research, 2012-06, Vol.42 (6), p.591-600

2012

Link zum Volltext

Verfügbarkeit prüfen

Green tea polyphenol epigallocatechin-3-gallate inhibits platelet-derived growth factor-induced proliferation of human hepatic stellate cell line LI90

Journal of hepatology, 2004, Vol.40 (1), p.52-59

2004

Link zum Volltext

Verfügbarkeit prüfen

Cell cycle regulation by the Wee1 inhibitor PD0166285, pyrido [2,3-d] pyimidine, in the B16 mouse melanoma cell line

BMC cancer, 2006-12, Vol.6 (1), p.292-292, Article 292

2006

Link zum Volltext

Verfügbarkeit prüfen

CD14 expression and Kupffer cell dysfunction in non-alcoholic steatohepatitis: Superparamagnetic iron oxide-magnetic resonance image and pathologic correlation

Journal of gastroenterology and hepatology, 2012-04, Vol.27 (4), p.789-796

2012

Link zum Volltext

Verfügbarkeit prüfen

Interaction of endothelial progenitor cells expressing cytosine deaminase in tumor tissues and 5‐fluorocytosine administration suppresses growth of 5‐fluorouracil‐sensitive liver cancer in mice

Cancer science, 2012-03, Vol.103 (3), p.542-548

2012

Link zum Volltext

Verfügbarkeit prüfen

Metronomic S-1 Chemotherapy and Vandetanib: An Efficacious and Nontoxic Treatment for Hepatocellular Carcinoma

Neoplasia (New York, N.Y.), 2011-03, Vol.13 (3), p.187-197

2011

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 230

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(191)
Mit Volltextzugriff
(200)

Publikationsform

Sprache

Englisch
(216)
Japanisch
(73)

Erscheinungsjahr

n.n

Thema

Science & Technology
(142)
Life Sciences & Biomedicine
(136)
Humans
(115)
Male
(84)
Biological And Medical Sciences
(67)
Female
(59)
Medical Sciences
(58)
Middle Aged
(58)
Gastroenterology & Hepatology
(54)
Animals
(49)
Adult
(44)
Gastroenterology. Liver. Pancreas. Abdomen
(36)
Aged
(34)
Liver. Biliary Tract. Portal Circulation. Exocrine Pancreas
(34)
Tumors
(27)
Immunohistochemistry
(26)
Oncology
(23)
Liver - Metabolism
(22)
Mice
(22)
Liver - Pathology
(20)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Aerobic vs. resistance exercise in non-alcoholic fatty liver disease: A systematic review

Characteristics of non-obese non-alcoholic fatty liver disease: Effect of genetic and environmental factors

Wheat-bran autolytic peptides containing a branched-chain amino acid attenuate non-alcoholic steatohepatitis via the suppression of oxidative stress and the upregulation of AMPK/ACC in high-fat diet-fed mice

Association of polymorphisms in GCKR and TRIB1 with nonalcoholic fatty liver disease and metabolic syndrome traits

Hepatitis C Virus Down-Regulates Insulin Receptor Substrates 1 and 2 through Up-Regulation of Suppressor of Cytokine Signaling 3

Luteolin promotes degradation in signal transducer and activator of transcription 3 in human hepatoma cells : An implication for the antitumor potential of flavonoids

Association of the rs738409 polymorphism in PNPLA3 with liver damage and the development of nonalcoholic fatty liver disease

Significance and Therapeutic Potential of Endothelial Progenitor Cell Transplantation in a Cirrhotic Liver Rat Model

Survival Benefit of Hepatic Arterial Infusion Chemotherapy over Sorafenib in the Treatment of Locally Progressed Hepatocellular Carcinoma

Association between obesity and polymorphisms in SEC16B, TMEM18, GNPDA2, BDNF, FAIM2 and MC4R in a Japanese population

Antiangiogenic and Antitumor Activities of Aflibercept, a Soluble VEGF Receptor-1 and -2, in a Mouse Model of Hepatocellular Carcinoma

Branched-Chain Amino Acid–Rich Supplements Containing Microelements Have Antioxidant Effects on Nonalcoholic Steatohepatitis in Mice

Vandetanib, an Inhibitor of VEGF Receptor-2 and EGF Receptor, Suppresses Tumor Development and Improves Prognosis of Liver Cancer in Mice

Pigment epithelium-derived factor (PEDF) inhibits survival and proliferation of VEGF-exposed multiple myeloma cells through its anti-oxidative properties

Targeted next-generation sequencing and fine linkage disequilibrium mapping reveals association of PNPLA3 and PARVB with the severity of nonalcoholic fatty liver disease

Transplantation of endothelial progenitor cells ameliorates vascular dysfunction and portal hypertension in carbon tetrachloride-induced rat liver cirrhotic model

Angiogenic cell therapy for hepatic fibrosis

Metronomic Chemotherapy: Possible Clinical Application in Advanced Hepatocellular Carcinoma

Hepatitis C virus core protein upregulates the expression of vascular endothelial growth factor via the nuclear factor-κB/hypoxia-inducible factor-1α axis under hypoxic conditions

Green tea polyphenol epigallocatechin-3-gallate inhibits platelet-derived growth factor-induced proliferation of human hepatic stellate cell line LI90

Cell cycle regulation by the Wee1 inhibitor PD0166285, pyrido [2,3-d] pyimidine, in the B16 mouse melanoma cell line

CD14 expression and Kupffer cell dysfunction in non-alcoholic steatohepatitis: Superparamagnetic iron oxide-magnetic resonance image and pathologic correlation

Genetic variations in the CYP17A1 and NT5C2 genes are associated with a reduction in visceral and subcutaneous fat areas in Japanese women

Interaction of endothelial progenitor cells expressing cytosine deaminase in tumor tissues and 5‐fluorocytosine administration suppresses growth of 5‐fluorouracil‐sensitive liver cancer in mice

Metronomic S-1 Chemotherapy and Vandetanib: An Efficacious and Nontoxic Treatment for Hepatocellular Carcinoma

Suchergebnisse filtern